Publikationer pr. år
Publikationer pr. år
-
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries
Glintborg, B., Georgiadis, S., Loft, A. G., Linauskas, A., Lindegaard, H., Hendricks, O., Jensen, D. V., Andersen, B. L., Danebod, K., Villumsen, A., Eng, G., Wiell, C., Manilo, N., Kristensen, S., Raun, J., Grydehøj, J., Chrysidis, S., Nørgaard, M., Mehnert, F. & Krogh, N. S. & 1 flere, , jun. 2020, I: Annals of the Rheumatic Diseases. 79, 6, s. 846-848 3 s.Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review
-
Antibodies to infliximab and adalimumab in patients with rheumatoid arthritis in clinical remission: a cross-sectional study
Eng, G. P., Bendtzen, K., Bliddal, H., Stoltenberg, M., Szkudlarek, M., Fana, V., Lindegaard, H. M., Omerovic, E., Højgaard, P., Jensen, E. K. & Bouchelouche, P. N., 2015, I: Arthritis. 2015, s. 784825Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review
Åben adgang -
Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose
Eng, G., Stoltenberg, M. B., Szkudlarek, M., Bouchelouche, P. N., Christensen, R., Bliddal, H. & Marie Bartels, E., okt. 2013, I: Seminars in Arthritis and Rheumatism. 43, 2, s. 144-51 8 s.Publikation: Bidrag til tidsskrift › Review › Forskning › peer review